Literature DB >> 21646296

FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid.

Kelly N Messingham1, Rupasree Srikantha, Amy M DeGueme, Janet A Fairley.   

Abstract

Bullous pemphigoid (BP) is a subepidermal blistering disease characterized by IgE and IgG class autoantibodies specific for 180-kDa BP Ag 2 (BP180), a protein involved in cell-substrate attachment. Although some direct effects of BP IgG have been observed on keratinocytes, no study to date has examined direct effects of BP IgE. In this study, we use primary cultures of human keratinocytes to demonstrate Ag-specific binding and internalization of BP IgE. Moreover, when BP IgE and BP IgG were compared, both isotypes stimulated FcR- independent production of IL-6 and IL-8, cytokines critical for BP pathology, and elicited changes in culture confluence and viability. We then used a human skin organ culture model to test the direct effects of these Abs on the skin, whereas excluding the immune inflammatory processes that are triggered by these Abs. In these experiments, physiologic concentrations of BP IgE and BP IgG exerted similar effects on human skin by stimulating IL-6 and IL-8 production and decreasing the number of hemidesmosomes localized at the basement membrane zone. We propose that the Ab-mediated loss of hemidesmosomes could weaken attachment of basal keratinocytes to the basement membrane zone of affected skin, thereby contributing to blister formation. In this article, we identify a novel role for IgE class autoantibodies in BP mediated through an interaction with BP180 on the keratinocyte surface. In addition, we provide evidence for an FcR-independent mechanism for both IgE and IgG class autoantibodies that could contribute to BP pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21646296     DOI: 10.4049/jimmunol.1001753

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 3.  Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.

Authors:  K A N Messingham; H M Holahan; J A Fairley
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 4.  Basement membranes and autoimmune diseases.

Authors:  Mary H Foster
Journal:  Matrix Biol       Date:  2016-08-02       Impact factor: 11.583

5.  From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.

Authors:  Ralf J Ludwig; Luca Borradori; Luis A Diaz; Takashi Hashimoto; Michael Hertl; Saleh M Ibrahim; Marcel F Jonkman; Yasuo Kitajima; Dédée F Murrell; Enno Schmidt; Hiroshi Shimizu; John R Stanley; David T Woodley; Detlef Zillikens
Journal:  J Invest Dermatol       Date:  2014-09       Impact factor: 8.551

6.  Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180.

Authors:  Kelly A N Messingham; Amber Onoh; Elizabeth M Vanderah; George J Giudice; Janet A Fairley
Journal:  Hybridoma (Larchmt)       Date:  2012-04

7.  Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.

Authors:  Stefan Tukaj; Denise Grüner; Detlef Zillikens; Michael Kasperkiewicz
Journal:  Cell Stress Chaperones       Date:  2014-05-06       Impact factor: 3.667

Review 8.  Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Authors:  Hideyuki Ujiie; David Rosmarin; Michael P Schön; Sonja Ständer; Katharina Boch; Martin Metz; Marcus Maurer; Diamant Thaci; Enno Schmidt; Connor Cole; Kyle T Amber; Dario Didona; Michael Hertl; Andreas Recke; Hanna Graßhoff; Alexander Hackel; Anja Schumann; Gabriela Riemekasten; Katja Bieber; Gant Sprow; Joshua Dan; Detlef Zillikens; Tanya Sezin; Angela M Christiano; Kerstin Wolk; Robert Sabat; Khalaf Kridin; Victoria P Werth; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2022-06-09

9.  Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm.

Authors:  Akiko Imanishi; Hisayoshi Imanishi; Sho Hiroyasu; Toshiyuki Ozawa; Hiroshi Koga; Norito Ishii; Yasuo Kitajima; Takashi Hashimoto; Daisuke Tsuruta
Journal:  Med Mol Morphol       Date:  2015-12-10       Impact factor: 2.309

10.  Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway.

Authors:  Sho Hiroyasu; Toshiyuki Ozawa; Hiromi Kobayashi; Masamitsu Ishii; Yumi Aoyama; Yasuo Kitajima; Takashi Hashimoto; Jonathan C R Jones; Daisuke Tsuruta
Journal:  Am J Pathol       Date:  2013-01-19       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.